Press Releases

and/or
567 News Releases found
Mini Kamboj, MD
According to a new study from Memorial Sloan Kettering published June 24 in Nature Medicine, patients in active cancer treatment who develop COVID-19 infection don’t fare any worse than other hospitalized patients. Researchers say their findings suggest that no one should delay cancer treatment because of concerns about the virus.
MSK Logo
The success of science, research, and medicine in saving and extending lives requires the transfer of ideas and knowledge in the laboratory, classroom, hospitals and clinics. The Executive Order issued on June 22 that suspends the issuing of temporary visas for certain foreign workers will only impede the innovation and scientific leadership that the world has come to expect from the United States.
MSK-Impact
A study from Memorial Sloan Kettering found that young patients ages 18 to 39 with early-onset cancer have an especially high risk of harboring inherited genetic (germline) mutations.
Memorial Sloan Kettering Cancer Center (MSK) announces the following awards and honors, given by the American Association for Cancer Research (AACR), the American Society of Clinical Oncology (ASCO), and the American Society of Hematology (ASH) organizations.
Visible Ink
On Thursday, June 18th at 6:00 p.m. E.T. with an encore at 9:00 p.m., MSK will stream a special performance highlighting poignant and humorous perspectives On Cancer and Coronavirus, featuring works from its writing program, Visible Ink.
A MSK Kids patient with his MSK Kids Nurse Practitioner
MSK Kids, the pediatric oncology program at Memorial Sloan Kettering Cancer Center (MSK) has been named one of the best children’s hospitals nationally, according to U.S. News & World Report in its annual “Best Children’s Hospitals” list. MSK Kids is ranked 13th in the nation. MSK Kids has been ranked by U.S. News & World Report for the past 12 years.
MSK Awards & Appointments
Memorial Sloan Kettering Cancer Center (MSK) announces its most recent awards and appointments for the institution’s physicians, scientists, nurses, and staff.
Charles L. Sawyers, MD
The Fellows of the American Association for Cancer Research (AACR) have elected Charles L. Sawyers, MD, chair of the Human Oncology and Pathogenesis Program (HOPP) at Memorial Sloan Kettering Cancer Center (MSK), as their President-Elect for 2020–2021.
MSK Bergen
The Memorial Sloan Kettering – Hackensack Meridian Health Partnership has formed an Immunology Research Collaboration to support innovative investigations into the power of the immune system to fight cancer.
Blue flag with Memorial Sloan Kettering logo
A Letter to the MSK Community
Read a letter from Memorial Sloan Kettering's leadership team about our commitment to our community in response to acts of racism and discrimination.